Legend Total Debt

LEGN Stock

USD 63.94 0.81 1.28%

Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

As of 31st of May 2023, Total Debt is likely to grow to about 307 M.

Current Assets Total Assets

Legend Total Debt Analysis

Legend BiotechCorp's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Legend BiotechCorp Total Debt

307 Million

Total Debt

Bonds

Notes

More About Total Debt | All Equity Analysis

Current Legend BiotechCorp Total Debt

260.93 M

Most of Legend BiotechCorp's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Total Debt. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.

Legend Total Debt Historical Pattern

Today, most investors in Legend BiotechCorp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Legend BiotechCorp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Legend BiotechCorp total debt as a starting point in their analysis.

Legend BiotechCorp Total Debt

Timeline

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Competition

Predict Legend BiotechCorp

Total Debt Over Time

Based on the latest financial disclosure, Legend BiotechCorp has a Total Debt of 260.93 M. This is 90.52% lower than that of the Biotechnology sector and 19.66% lower than that of the Health Care industry. The total debt for all United States stocks is 95.09% higher than that of the company.

Legend Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.

Legend BiotechCorp is currently under evaluation in total debt category among related companies.

Legend Fundamentals

	Return On Equity	(0.96) %
	Return On Asset	(0.29) %
	Operating Margin	(5.00) %
	Current Valuation	8.02 B
	Shares Outstanding	180.35 M
	Shares Owned by Insiders	1.42 %
	Shares Owned by Institutions	39.26 %
	Number of Shares Shorted	4.68 M
	Price to Book	19.80 X
	Price to Sales	73.18 X
	Revenue	117 M
	Gross Profit	(284.01 M)
	EBITDA	(437.44 M)
	Net Income	(445.72 M)
	Cash and Equivalents	791.26 M
	Cash per Share	5.11 X
	Total Debt	260.93 M
	Debt to Equity	0.29 %
	Current Ratio	3.83 X
	Book Value Per Share	3.95 X
	Cash Flow from Operations	(200.03 M)
	Short Ratio	3.70 X
	Earnings Per Share	(3.14) X
	Target Price	80.9
	Number of Employees	1.39 K
	Beta	-0.0584
	Market Capitalization	11.39 B
	Total Asset	1.33 B
	Working Capital	801.33 M
	Z Score	25.91
	Net Asset	1.33 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

		Last Reported	Projected for 2023
	Total Debt	284.5 M	307 M

Legend BiotechCorp Investors Sentiment

The influence of Legend BiotechCorp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend BiotechCorp.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend BiotechCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend BiotechCorp's short interest history, or implied volatility extrapolated from Legend BiotechCorp options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.639

Quarterly Revenue Growth

(0.12)

Return On Assets

(0.29)

Return On Equity

(0.96)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Investments Current	Total Liabilities	Current Liabilities	Tax Assets	Tax Liabilities
Total Assets		1.0	0.99	0.91	0.84	0.88	0.84	0.63	0.96	-0.79	-0.72
Current Assets	1.0		0.99	0.9	0.83	0.88	0.83	0.61	0.95	-0.78	-0.73
Cash and Equivalents	0.99	0.99		0.86	0.79	0.86	0.76	0.52	0.91	-0.7	-0.78
Total Debt	0.91	0.9	0.86		0.94	0.94	0.98	0.82	0.97	-0.96	-0.65
Debt Current	0.84	0.83	0.79	0.94		0.98	0.95	0.89	0.87	-0.96	-0.74
Deferred Revenue	0.88	0.88	0.86	0.94	0.98		0.92	0.8	0.87	-0.91	-0.84
Investments Current	0.84	0.83	0.76	0.98	0.95	0.92		0.91	0.93	-0.99	-0.56
Total Liabilities	0.63	0.61	0.52	0.82	0.89	0.8	0.91		0.75	-0.95	-0.41
Current Liabilities	0.96	0.95	0.91	0.97	0.87	0.87	0.93	0.75		-0.89	-0.58
Tax Assets	-0.79	-0.78	-0.7	-0.96	-0.96	-0.91	-0.99	-0.95	-0.89		0.54
Tax Liabilities	-0.72	-0.73	-0.78	-0.65	-0.74	-0.84	-0.56	-0.41	-0.58	0.54

Legend Total Debt

Legend Total Debt Analysis

Legend BiotechCorp Total Debt

307 Million

Current Legend BiotechCorp Total Debt

Legend Total Debt Driver Correlations

Legend Total Debt Historical Pattern

Legend Total Debt Peer Comparison

Legend Fundamentals

About Legend BiotechCorp Fundamental Analysis

Legend BiotechCorp Investors Sentiment

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY